Contribution: Industrial Research Assistance Program – Contributions to Firms
Sanotize Research & Development Corp.
$400,000.00
COVID-19 Response Nitric Oxide to Prevent and Treat mild to moderate COVID-19 (Coronavirus disease 2019)
FY 2020-21 · 2020-04-23
Summary
Evaluating NORS Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers & Individuals at Risk of Infection.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
North Vancouver|North Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
710549726
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-04-23 | 2020-21 | $400,000.00 |
| 1 | 2020-04-23 | 2020-21 | $400,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 182 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 182 jours.
Agreement End Date
2021-03-31
Agreement Number
948557
Agreement Start Date
2020-04-23
Agreement Title
COVID-19 Response Nitric Oxide to Prevent and Treat mild to moderate COVID-19 (Coronavirus disease 2019)
Agreement Title (French)
Réponse à la COVID-19 - L'oxyde nitrique pour prévenir et traiter les cas légers à modérés de COVID-19 (maladie à coronavirus 2019)
Agreement Type
Contribution
Agreement Value
$400,000.00
Amendment Date
2020-09-16
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Evaluating NORS Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers & Individuals at Risk of Infection.
Description (French)
Évaluation du traitement NORS pour la prévention et le traitement de la COVID-19 chez les travailleurs de la santé et les personnes à risque d'infection.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Burnaby North--Seymour
Federal Riding (French)
Burnaby-Nord--Seymour
Federal Riding Number
59002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
710549726
Recipient City
North Vancouver|North Vancouver
Recipient Country
CA
Recipient Legal Name
Sanotize Research & Development Corp.
Recipient Postal Code
V7H 2Y4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q1-948557
